Speak directly and say only what you mean. Be loyal to the things you say you are going to do. Keep your promises.

Dudnyk Wins PM360 Trailblazer Award for Philanthropic Initiative

Simon’s Heart awarded Best Consumer Website/Online Initiative

Dudnyk's Tim Anderson on the Enduring Value of Chemotherapy in Cancer Care

In the new age of innovative oncology therapies, chemotherapy still plays a critical role in cancer care.

Agency CEO Roundtable

In the September issue of PharmaVOICE, Chris Tobias discusses why the strength of the empowered patient is the greatest fundamental shift in our industry.

Dudnyk Named Finalist for Multiple Trailblazer Awards

Dudnyk is proud to have been named a finalist five times for the upcoming PM360 Magazine #TrailblazerAwards.

Drew Desjardins Named to PharmaVOICE 100

Drew Desjardins has been recognized as one of the inspirational leaders of our industry. Read what our “Chief Problem Solver” has to say about collaborative thinking and groundbreaking strategy.

Dudnyk Shortlisted for Four MM&M Awards

Dudnyk has been nominated in four categories for this year’s MM&M Awards, including for our philanthropic and rare disease work.

Dudnyk Listed as Top 100 Agency in July MM&M

Dudnyk has been listed again in the annual agency issue. Read to learn more about our revenue increases, recent growth, and ongoing projects.

From Isolation to Anticipation

Laurie Bartolomeo shares how technology continues to improve the lives of rare disease families in the July issue of MedAd News.

WOW! Laurie Bartolomeo Featured in PharmaVOICE Woman of the Week Podcast

Laurie Bartolomeo talks to PharmaVOICE about her career journey and how her son’s rare disease is a source of inspiration.

Dudnyk Featured in April Med Ad News

The April agency issue of Med Ad News highlighted Dudnyk as Agency of the Year.

Dudnyk Named Agency of the Year

Agency Earns Top Honors from Med Ad News at the 30th Annual Manny Awards.

Patient Journeys Are Never Linear

Drew Desjardins talks about why no two rare disease journeys are ever alike in the April issue of PharmaVOICE.

Children on the Frontline: The Toll of Rare Diseases

Laurie Bartolomeo shares how her personal experience drives her passion in the April issue of PharmaVOICE.

Simon's Heart "Protect Your Heart" Featured in PM360's Greatest Creators

Dudnyk partnered with Philadelphia-based, nonprofit Simon's Heart to help raise awareness of sudden cardiac arrest (SCA) - the #1 killer of student athletes. The "Protect Your Heart" Campaign was highlighted as a Showcase Feature in PM360.

Moving the Needle on Your Brand

Chief Strategy Officer Drew Desjardins shared his thoughts on crafting persuasive communications in PM360's March Think Tank.

Dudnyk Joins Fishawack Group of Companies; Expands Service Offering and Global Reach

Dudnyk leaders announce the next phase in its evolution as an ever-growing organization by joining The Fishawack Group of Companies.

Dudnyk Expands Creative Leadership Team to Support Growing Client Needs

Kristin Morris and Dawn Hastings were promoted to VP, Creative Director with expanded responsibilities and strategic oversight over several key accounts.

The Future of Medicine is Here

Senior Scientific Director Jahda Hill, PhD, looks at how revolutionary therapeutic approaches are transforming the rare disease space. Read it now in the latest issue of PharmaVOICE:

Rare difficulties

Chris Tobias and Laurie Bartolomeo discuss the the greatest challenges facing rare disease marketers in the latest issue of PharmaVOICE.

Healthcare Agency Roundtable

Chris Tobias and Laurie Bartolomeo share their views on industry trends and developments in the MedAdNews annual report.